Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair
Askel Healthcare to raise 5 million euros for clinical research of its COPLA® -implant to treat knee pain caused by cartilage damage
Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA
First research patient operated in Estonia with Askel Healthcare’s COPLA® knee cartilage repair implant